Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease

Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Keikawus Arastéh(Auguste-Viktoria-Klinik), Heinz‐August Horst(Goethe University Frankfurt), Christian Teutsch(Helios Hospital Berlin-Buch), Stefan Reuter(University Hospital Münster), Holger Schmid(München Klinik), Michael Sabranski, Markus Müller, Stefan Eßer(Essen University Hospital), Jan van Lunzen(Universidade Federal de São Paulo), Christoph Wyen, Hans Jäger, Timo Wolf(Goethe University Frankfurt), Martin Vogel(Janssen (United States)), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation)
Blood
July 22, 2011
10.1182/blood-2011-02-333633
Cited by 92

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
|Blood|2005|537